Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

Coor - Denmark masks underlying improvements

16 juli 2026

<a id="bm-comp-2c69e783-9cf0-421b-b042-0ef87fcfc45d" name="bm-comp-2c69e783-9cf0-421b-b042-0ef87fcfc45d" class="BMCustomAnchor"></a><table><tr><td bm-component-id="2c69e783-9cf0-421b-b042-0ef87fcfc45d" style="vertical-align: top; width:100.000000%;"><ul><li>We cut '26e-'28e adj. EBITA by 1% on temporary DK weakness</li><li>Positive development below surface, should be more visible from Q4</li><li>Fair value range maintained at SEK 40-80 per share</li></ul></td></tr></table><a id="bm-comp-b9b5cb64-9693-4286-8ebc-a4e925d93664" name="bm-comp-b9b5cb64-9693-4286-8ebc-a4e925d93664" class="BMCustomAnchor"></a><table><tr><td bm-component-id="b9b5cb64-9693-4286-8ebc-a4e925d93664" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Denmark overshadowed underlying improvements</h3><p>Coor delivered a stable Q2 report, although margins in Denmark surprised a bit negatively, resulting in adj. EBITA 2% below our expectation (adj. EBITA +3% y-o-y). Denmark earnings were expected to be soft due to the announced contract losses in late 2025, but the margin of 2.8% (vs. 3.7% in Q1) was surprising. Management highlighted that the contract losses have resulted in additional challenges within delivery, which should be of a temporary nature as the Danish business recalibrates. As such, we slightly lower Denmark H2'26 EBITA, but do not extrapolate the weak Q2 margin. Meanwhile, the rest of the business is showing promising signs. Norway is holding up well against unusually high variable volumes last year, and both Sweden and Finland grew organically and improved margins. Management also highlighted promising tendering activity. For this reason, we anticipate accelerated adj. EBITA growth in the coming quarters (6%/14% y-o-y in Q3/Q4).</p><h3 class="bm-h3">Limited changes to '26e-'28e adj. EBITA</h3><p>We cut sales and adj. EBITA by 1% for '26e-'28e, respectively. The effect on 2026 EBIT and EPS is greater, mainly due to restructuring costs incurred in Q2, as well as an SEK 20m one-off cost in Q3 resulting from an unfavourable ruling in Denmark regarding a customer case from 2022.</p><h3 class="bm-h3">The new strategy to bear fruit from Q4</h3><p>While Q3 will likely remain pressured by tough comps and the challenges in Denmark, we think Coor will return to solid earnings growth from Q4, supported by the new strategy presented at the CMD, which we find convincing. By returning to organic growth, and reaching margins &gt;5.5% over the coming year, we see strong adj. EPS growth, cash generation and a solid gearing of 2.2x in 2027. The share is trading at 10x adj. P/E and P/FCF on 2027e, with 5% dividend yield.</p></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-07-24 Cavotec - Low-margin legacy orders weigh on Q2 Cavotec Analys
2026-07-24 Cavotec - P&M order momentum sustained Cavotec Analys
2026-07-22 Inission - Strong trend to continue Inission Analys
2026-07-22 SinterCast - Q2 still tough, but we see tailwinds... SinterCast Analys
2026-07-22 Medicover - No symptoms of surprise in Q2 Medicover Analys
2026-07-22 Ework Group - Cautious optimism Ework Group Analys
2026-07-22 Donkey Republic - Helsinki deal offers further de... Donkey Repu.. Analys
2026-07-22 Medicover - In line report, reiterated targets Medicover Analys
2026-07-21 Embellence Group - Broad progress in the DTC stra... Embellence .. Analys
2026-07-21 Eltel - Earnings improve, but less than we hoped Eltel Analys
2026-07-21 CTT Systems - Getting closer to lift-off CTT Systems Analys
2026-07-21 CTT Systems - Better Q2 and OK FY'26 guidance on ... CTT Systems Analys
2026-07-21 Ework Group - Order intake turns the corner Ework Group Analys
2026-07-21 Embellence Group - Sales miss, margins resilient Embellence .. Analys
2026-07-20 Studsvik - DRPS turns, Scandpower awaits H2 Studsvik Analys
2026-07-20 Qliro - NCI miss, but TPV growth still healthy Qliro Analys
2026-07-20 Ferronordic - Positioning itself for a strong H2 Ferronordic Analys
2026-07-19 Prevas - Organic recovery delayed further Prevas Analys
2026-07-19 Ovzon - Ramping costs now for bigger wins later Ovzon Analys
2026-07-19 Alligo - Finland again ahead of plan in a solid Q2 Alligo Analys